Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder (GOLD)

This study has been completed.
Information provided by:
AstraZeneca Identifier:
First received: May 22, 2006
Last updated: March 24, 2009
Last verified: March 2009